FutureHealth conference brings international experts to Basel
The FutureHealth Basel conference brought together experts, startups and those affected by digital healthcare. In addition to exploring the opportunities and challenges associated with digital healthcare, the conference also focused on strengthening the regional life sciences cluster.
Deep Dive Session of the DayOne Accelerator at FutureHealth Basel (img: Nirnberger)
The third FutureHealth Basel conference took place in the Congress Center Basel on Tuesday. Titled “Me, Myself and Algorithms”, the conference focused on the future of healthcare and the tension between digitization, people and profits. Over the course of the conference, it became clear that Switzerland should take a pioneering role in digitizing the healthcare system. Data security was also an important topic.
The conference brought a number of international experts to Basel, a city that is strongly influenced by life sciences. Speakers included Eugene Borukhovich, founder of the American company YourCoach Health, and Bart De Witte, a leading expert in digital health, both of whom spoke about the role of algorithms in the diagnostic process, among other topics.
Pamela Peele, Chief Analytics Officer at UPMC Enterprises, an American healthcare company and insurer, was another of the speakers. She explained that her company has incentives to keep patients healthy because it combines insurance and services under one roof. A discussion was also held on how such a model could be implemented in Switzerland.
Parallel to the main sessions, the conference also offered a wide range of what it calls ‘Deep Dive’ sessions, which looked at the role of artificial intelligence in healthcare or global cooperation in health data. Another topic was the challenge of an electronic healthcare economy in Switzerland. “This seminal topic is essential for strengthening and advancing the regional life sciences cluster,” said Martin Dätwyler, director of the Basel Chamber of Commerce.
The conference was organized by the Basel Chamber of Conference and NZZ Konferenzen, and conference partners included BaselArea.swiss. It participated in the event with its DayOne Accelerator program, which supports startups active in the field of digital health. Several startups presented their ideas at the conference and received valuable feedback. They were also able to make new contacts.
Share this article
You might also be interested in
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.Read More
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..Read More
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.Read More
Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.Read More
The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.Read More
The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.Read More